Antibiotic gross sales decreased 53% between 2011 and 2022
14 December 2023
3 minute learn
European nations have considerably diminished gross sales of veterinary antibiotics, which interprets right into a decrease threat of micro organism changing into resistant in individuals and animals, in response to a latest report from the European Medicines Company. General gross sales of veterinary antibiotics decreased by 53% between 2011 and 2022, reaching the bottom degree ever reported, in response to knowledge from 25 nations. This is likely one of the key findings of the thirteenth annual report on the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC): 2009 – 2023.
Throughout the identical interval, gross sales of antibiotic lessons which are thought of critically vital in human medication for veterinary use noticeably decreased: gross sales of third- and fourth-generation cephalosporins dropped by 49%, polymyxins by 81%, fluoroquinolones by 25% and gross sales of different quinolones dropped by 90%. Whereas all antibiotics must be used prudently and responsibly to protect their effectiveness, it’s of specific significance for these antibiotics to mitigate the potential threat to public well being, as indicated within the Antimicrobial Recommendation advert hoc Professional Group (AMEG) categorisation.
“The gathering of information on gross sales of veterinary antimicrobials has been crucial in shaping coverage initiatives, assessing the impression of present measures and setting targets that help in tackling the emergence of antimicrobial resistance,” stated Ivo Claassen, head of EMA’s Veterinary Medicines Division.
EMA has been monitoring gross sales of veterinary antimicrobials in Europe by way of the ESVAC challenge since 2009, when 9 European nations volunteered to offer knowledge on gross sales of veterinary antimicrobials. The variety of taking part nations has elevated greater than three-fold because the begin, and in 2022, 31 European nations have been working collectively on this challenge.
ESVAC has led to the gathering of dependable knowledge on antimicrobials offered to be used in animals, offering invaluable insights for taking part nations on the impression of their measures to advertise the prudent use and setting targets to scale back the consumption of antimicrobials in animals.
The ESVAC challenge is a European success story about dedication and robust collaboration. The challenge is coming to an finish in 2023 and EMA will publish the final ESVAC report with knowledge from 2022. The ESVAC idea has been built-in into the EU laws, making the gathering of information necessary for all EU nations, not just for gross sales of veterinary antimicrobials however within the coming years additionally to be used of antimicrobials in animals. The primary report with gross sales and use knowledge from 2023 will likely be printed in 2025.
The final ESVAC report additionally consists of data on the progress made in the direction of the targets set within the European Fee’s Farm to Fork Technique to scale back the sale of antimicrobials for farmed animals and aquaculture within the EU. In 2022, the 27 EU Member States have achieved simply over half of the 50% discount goal set for 2030 in comparison with 2018, proving that nations are heading in the right direction of assembly the objectives of the technique.
